ITMI922331A0 - Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione - Google Patents

Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione

Info

Publication number
ITMI922331A0
ITMI922331A0 IT92MI2331A ITMI922331A ITMI922331A0 IT MI922331 A0 ITMI922331 A0 IT MI922331A0 IT 92MI2331 A IT92MI2331 A IT 92MI2331A IT MI922331 A ITMI922331 A IT MI922331A IT MI922331 A0 ITMI922331 A0 IT MI922331A0
Authority
IT
Italy
Prior art keywords
paratormone
gestation
abortion
therapy
prevention
Prior art date
Application number
IT92MI2331A
Other languages
English (en)
Inventor
Franco Bagnoli
Original Assignee
Franco Bagnoli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franco Bagnoli filed Critical Franco Bagnoli
Publication of ITMI922331A0 publication Critical patent/ITMI922331A0/it
Priority to ITMI922331A priority Critical patent/IT1255723B/it
Priority to US08/411,726 priority patent/US5880093A/en
Priority to DK93922531.4T priority patent/DK0663835T3/da
Priority to EP93922531A priority patent/EP0663835B1/en
Priority to AU51499/93A priority patent/AU680631B2/en
Priority to KR1019950701350A priority patent/KR100293846B1/ko
Priority to AT93922531T priority patent/ATE152628T1/de
Priority to DE69310528T priority patent/DE69310528T2/de
Priority to CA002146666A priority patent/CA2146666A1/en
Priority to JP6509588A priority patent/JPH08502271A/ja
Priority to ES93922531T priority patent/ES2103493T3/es
Priority to NZ256679A priority patent/NZ256679A/en
Priority to PCT/EP1993/002755 priority patent/WO1994008613A2/en
Publication of ITMI922331A1 publication Critical patent/ITMI922331A1/it
Priority to NO19951050A priority patent/NO317930B1/no
Application granted granted Critical
Publication of IT1255723B publication Critical patent/IT1255723B/it
Priority to GR970401802T priority patent/GR3024157T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ITMI922331A 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione IT1255723B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
CA002146666A CA2146666A1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
ES93922531T ES2103493T3 (es) 1992-10-09 1993-10-08 Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
EP93922531A EP0663835B1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
AU51499/93A AU680631B2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
KR1019950701350A KR100293846B1 (ko) 1992-10-09 1993-10-08 임신치료를위한파라소먼,그생물학적활성프래그먼트및관련펩티드의용도
AT93922531T ATE152628T1 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE69310528T DE69310528T2 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
US08/411,726 US5880093A (en) 1992-10-09 1993-10-08 Use of parathormone, its biologically active fragments and correlated peptides, for the preparation of pharmaceutical compositions useful for the treatment of pregnancy
JP6509588A JPH08502271A (ja) 1992-10-09 1993-10-08 パラトルモン、その生物学的活性フラグメント及び関連ペプチドの妊娠時の治療への使用
DK93922531.4T DK0663835T3 (da) 1992-10-09 1993-10-08 Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
NZ256679A NZ256679A (en) 1992-10-09 1993-10-08 Use of parathormone (parathyroid hormone) in prevention and therapy of abortion and of premature birth
PCT/EP1993/002755 WO1994008613A2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
NO19951050A NO317930B1 (no) 1992-10-09 1995-03-20 Anvendelse av paratyroidhormon, dets biologisk aktive fragmenter og korrelerte peptider for fremstilling av farmasoytiske blandinger for behandling under svangerskap.
GR970401802T GR3024157T3 (en) 1992-10-09 1997-07-17 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Publications (3)

Publication Number Publication Date
ITMI922331A0 true ITMI922331A0 (it) 1992-10-09
ITMI922331A1 ITMI922331A1 (it) 1994-04-09
IT1255723B IT1255723B (it) 1995-11-13

Family

ID=11364090

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Country Status (14)

Country Link
US (1) US5880093A (it)
EP (1) EP0663835B1 (it)
JP (1) JPH08502271A (it)
KR (1) KR100293846B1 (it)
AT (1) ATE152628T1 (it)
AU (1) AU680631B2 (it)
CA (1) CA2146666A1 (it)
DE (1) DE69310528T2 (it)
DK (1) DK0663835T3 (it)
ES (1) ES2103493T3 (it)
GR (1) GR3024157T3 (it)
IT (1) IT1255723B (it)
NZ (1) NZ256679A (it)
WO (1) WO1994008613A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
DK0811383T3 (da) * 1995-02-20 2007-06-25 Yukio Kato Lægemidler til arthrosis deformans og inflammatoriske ledsygdomme
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US6043981A (en) * 1997-11-13 2000-03-28 Chrysler Corporation Heat sink assembly for electrical components
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
ZA9811127B (en) † 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
AU1447600A (en) * 1998-10-22 2000-05-08 Thomas J. Gardella Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
EP1439854B1 (en) * 2001-07-23 2016-12-14 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
US7521528B2 (en) * 2003-01-24 2009-04-21 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs with lactam bridges
JP4334480B2 (ja) * 2003-03-19 2009-09-30 ザ ジェネラル ホスピタル コーポレイション α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン
US7910544B2 (en) 2003-07-17 2011-03-22 The General Hospital Corporation Conformationally constrained parthyroid hormone (PTH) analogs
MXPA06013168A (es) 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
EP1767541A4 (en) * 2004-05-26 2008-10-22 Greenpeptide Co Ltd HLA-A24 OR HLA-A2-RELATED PEPTIDE OF PARATHORMONE-RELATED PROTEIN
US8143374B2 (en) * 2006-08-04 2012-03-27 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
MX353986B (es) 2007-08-01 2017-11-06 Massachusetts Gen Hospital Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas.
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
KR0131678B1 (ko) * 1991-12-09 1998-04-17 유미꾸라 레이이찌 파라티로이드 호르몬류의 안정화 조성물
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone

Also Published As

Publication number Publication date
WO1994008613A3 (en) 1994-05-26
DK0663835T3 (da) 1997-09-01
WO1994008613A2 (en) 1994-04-28
KR950703359A (ko) 1995-09-20
EP0663835A1 (en) 1995-07-26
ITMI922331A1 (it) 1994-04-09
CA2146666A1 (en) 1994-04-28
DE69310528T2 (de) 1997-09-11
ES2103493T3 (es) 1997-09-16
AU680631B2 (en) 1997-08-07
EP0663835B1 (en) 1997-05-07
KR100293846B1 (ko) 2001-09-17
JPH08502271A (ja) 1996-03-12
US5880093A (en) 1999-03-09
AU5149993A (en) 1994-05-09
NZ256679A (en) 1997-03-24
GR3024157T3 (en) 1997-10-31
ATE152628T1 (de) 1997-05-15
DE69310528D1 (de) 1997-06-12
IT1255723B (it) 1995-11-13

Similar Documents

Publication Publication Date Title
ITMI922331A0 (it) Uso di paratormone suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto protermine ed in generale per il trattamento della gestazione
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
IL152659A (en) Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
PT735818E (pt) Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y
ZA874635B (en) Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
IT9067434A0 (it) Procedimento per migliorare l'efficacia terapeutica di corticosteroidi liposolubili e composizione per l'attuazione di tale procedimento
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
HUP0001526A3 (en) Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions
ITRM910730A0 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" diradicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
IT1241631B (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
HUT71838A (en) Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
ITRM950589A0 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili
MY111746A (en) Therapeutic nucleosides.
CA2251355A1 (en) Il-6 mutein
IT8909484A0 (it) Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria
IT8619457A1 (it) Derivati insaturi cicloalifatici, loro procedimenti di preparazione e loro impiego in terapia e in cosmetica
ITMI922216A0 (it) Nitrobenzoilalanine procedimento per la loro preparazione loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030